Group One Trading
CLSD

Group One Trading’s Clearside Biomedical CLSD Stock Holding History

Group One Trading’s Portfolio CLSD Stock Details CLSD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q1 		– Sell
-33
Closed -$585 – 7148
2023
Q4 		$585 Sell
33
-334
-91% -$4.76K ﹤0.01% 7071
2023
Q3 		$4.78K Hold
367
– – ﹤0.01% 6720
2023
Q2 		$6.16K Buy
367
+34
+10% +$585 ﹤0.01% 6626
2023
Q1 		$5.2K Hold
333
– – ﹤0.01% 6260
2022
Q4 		$5.6K Sell
333
-334
-50% -$6.02K ﹤0.01% 6293
2022
Q3 		$11K Sell
667
-1,333
-67% -$29.2K ﹤0.01% 6416
2022
Q2 		$44K Sell
2,000
-140
-7% -$3.4K ﹤0.01% 5669
2022
Q1 		$74K Sell
2,140
-3,960
-65% -$118K ﹤0.01% 5777
2021
Q4 		$252K Buy
6,100
+1,327
+28% +$85.9K ﹤0.01% 4852
2021
Q3 		$430K Buy
4,773
+1,586
+50% +$140K ﹤0.01% 4362
2021
Q2 		$233K Buy
3,187
+2,340
+276% +$109K ﹤0.01% 5070
2021
Q1 		$31K Buy
+847
New +$42.5K ﹤0.01% 6527
2020
Q3 		– Sell
-43,380
Closed -$1.22M – 6123
2020
Q2 		$1.22M Sell
43,380
-667
-2% -$19.6K 0.01% 1847
2020
Q1 		$1.12M Buy
44,047
+13,787
+46% +$510K 0.01% 1436
2019
Q4 		$1.32M Buy
+30,260
New +$636K 0.01% 1644
2019
Q3 		– Sell
-6,587
Closed -$96K – 5184
2019
Q2 		$96K Hold
6,587
– – ﹤0.01% 3376
2019
Q1 		$136K Buy
+6,587
New +$131K ﹤0.01% 2964
2018
Q4 		– Sell
-533
Closed -$49K – 4923
2018
Q3 		$49K Sell
533
-2,554
-83% -$304K ﹤0.01% 3981
2018
Q2 		$495K Buy
3,087
+2,507
+432% +$423K ﹤0.01% 2298
2018
Q1 		$93K Buy
+580
New +$70.7K ﹤0.01% 3290

Other funds holding CLSD

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
CG
Carmignac Gestion Paris, France $6.51B AUM 19.13% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
GCP
GSA Capital Partners London, United Kingdom $1.61B AUM 28.28% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
First Manhattan
First Manhattan New York $36.1B AUM 11.5% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
BCM
Bridgeway Capital Management Houston, Texas $4.97B AUM 44.96% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Group One Trading's CLSD Position: Q4 2024 in Review

Group One Trading sold out of Clearside Biomedical (CLSD) in Q4 2024, closing a stake of 908 shares — an estimated $14.9K sold.

Group One Trading first reported a position in CLSD in Q1 2018 and held it in 19 quarters. The position peaked at $1.07M in Q2 2020. 43 funds tracked by Wall St. Rank hold CLSD as of Q4 2024.

  • Group One Trading reported no remaining Clearside Biomedical position as of Q4 2024 after selling out during the quarter.
  • Group One Trading sold 908 Clearside Biomedical shares in Q4 2024, an estimated $14.9K.
  • Group One Trading first reported a position in Clearside Biomedical in Q1 2018 and held it in 19 quarters.
  • Group One Trading's Clearside Biomedical position peaked at $1.07M in Q2 2020.
  • 43 funds tracked by Wall St. Rank held Clearside Biomedical as of Q4 2024.

Based on Group One Trading's 13F filing for Q4 2024, filed 14 Feb 2025.